Radiation Oncology Department, Stanford University Cancer Center, Palo Alto, California, USA.
Pediatr Blood Cancer. 2023 Oct;70(10):e30589. doi: 10.1002/pbc.30589. Epub 2023 Jul 24.
PURPOSE/OBJECTIVES: To evaluate dosimetric differences between auto-planned volumetric modulated arc therapy (VMAT) total body irradiation (TBI) technique and two-dimensional radiotherapy using anterior-posterial/posterio-anterial beams (2D AP/PA) TBI technique.
Ten pediatric patients treated with VMAT-TBI on Varian c-arm linac were included in this study. VMAT-TBI plans were generated using our in-house developed and publicly shared auto-planning scripts. For each VMAT-TBI plan, a 2D AP/PA plan was created replicating the institution's clinical setup with the patient positioned at extended source to skin distance (SSD) with a compensator to account for differences in patient thickness, 50% transmission daily lung blocks, and electron chest wall boosts prescribed to 50% of the photon prescription. Clinically relevant metrics were analyzed and compared between the VMAT and 2D plans.
All VMAT-TBI plans achieved planned target volume (PTV) D90% ≥ 100% of prescription. VMAT-TBI PTV D90% significantly increased (7.1% ± 2.9%, p < .001) compared to the 2D technique, whereas no differences were observed in global D (p < .2) and PTV V110% (p < .4). Compared to the 2D plans, significant decreases in the D to the lungs (-25.6% ± 11.5%, p < .001) and lungs-1 cm (-34.1% ± 10.1%, p < .001) were observed with the VMAT plans. The VMAT technique also enabled decrease of dose to other organs: kidneys D (-32.5% ± 5.0%, p < .001) and lenses D (-5.3% ± 8.1%, p = .03); and in addition, for 2 Gy prescription: testes/ovaries D (-41.5% ± 11.5%, p < .001), brain D (-22.6% ± 5.4%, p = .002), and thyroid D (-18.2% ± 16.0%, p = .03).
Superior lung sparing with improved target coverage and similar global D were observed with the VMAT plans as compared to 2D plans. In addition, VMAT-TBI plans provided greater dose reductions in gonads, kidneys, brain, thyroid, and lenses.
目的/目标:评估自动规划容积调强弧形治疗(VMAT)全身照射(TBI)技术与前后/后前光束二维放疗(2D AP/PA)TBI 技术之间的剂量学差异。
本研究纳入了 10 名在瓦里安 C 臂直线加速器上接受 VMAT-TBI 治疗的儿科患者。VMAT-TBI 计划是使用我们内部开发和公开共享的自动规划脚本生成的。对于每个 VMAT-TBI 计划,我们创建了一个 2D AP/PA 计划,该计划复制了机构的临床设置,患者在扩展源皮距(SSD)处定位,并使用补偿器来考虑患者厚度、50%的每日肺透射块和电子胸壁增强的差异,这些增强剂的剂量为光子处方的 50%。分析并比较了 VMAT 和 2D 计划的临床相关指标。
所有 VMAT-TBI 计划均实现了计划靶区(PTV)D90%≥处方的 100%。与 2D 技术相比,VMAT-TBI PTV D90%显著增加(7.1%±2.9%,p<.001),而全局 D (p<.2)和 PTV V110%(p<.4)无差异。与 2D 计划相比,VMAT 计划中肺(-25.6%±11.5%,p<.001)和肺-1cm(-34.1%±10.1%,p<.001)的剂量显著降低。VMAT 技术还能降低其他器官的剂量:肾脏 D(-32.5%±5.0%,p<.001)和晶状体 D(-5.3%±8.1%,p=.03);此外,对于 2Gy 处方:睾丸/卵巢 D(-41.5%±11.5%,p<.001)、脑 D(-22.6%±5.4%,p=.002)和甲状腺 D(-18.2%±16.0%,p=.03)。
与 2D 计划相比,VMAT 计划可更好地保护肺部,提高靶区覆盖率,同时保持相似的全局 D。此外,VMAT-TBI 计划可显著降低性腺、肾脏、大脑、甲状腺和晶状体的剂量。